期刊文献+

基质金属蛋白酶MMP-9在胃癌中的表达及其临床意义 被引量:6

The Expression and Significance of MMP- 9 of Matrix Metalloproteinases in Gastric Cancer
下载PDF
导出
摘要 目的:观察基质金属蛋白酶MMP-9在胃癌中的表达情况,探讨其在胃癌发生、发展中的临床意义。方法:采用免疫组化法,检测MMP-9在56例胃癌组织与24例正常胃粘膜中的表达情况。结果:56例原发性胃癌组织中,MMP-9阳性表达率为73.21%(41/56),高于24例正常胃粘膜的20.83%(5/24),两组比较差异有统计学意义(P<0.01);胃癌组织中MMP-9表达与TNM临床分期、淋巴结转移、浆膜浸润有关(P<0.01),与胃癌分化程度无相关性(P>0.05)。结论:基质金属蛋白酶MMP-9可能参与了胃癌发生发展过程,与胃癌的侵袭、转移密切相关,可作为判断胃癌预后的有重要参考价值的肿瘤标记物。 Objective: To observe the expression of MMP-9 in gastric cancer and to explore its clinical value in the occurrence, development of gastric cancer. Methods: The expressions of MMP-9 in gastric carcinoma tissues of 56 patients and normal gastric mucosa of 24 cases were detected by immunohistochemistry. Results: In 56 cases of primary gastric cancer, the positive rate of MMP-9 expression was 73.21% (41/56) , far higher than that of the normal gastric mucosa(20. 83% , 5/24). The difference was significant ( P 〈 0. 01 ) ; There was a positive correlation between the expression of MMP-9 and the TNM staging, lymph node metastasis and serosal invasion and no correlation was observed between the expression of MMP-9 and differentiation of gastric cancer( P 〉 0.05 ). Conclusion: Matrix metalloproteinase MMP-9 may be involved in the occurrence, development process, invasion and metastasis of gastric cancer. It can be used as an important tumor marker to judge the prognosis of gastric cancer.
出处 《肿瘤预防与治疗》 2012年第4期240-242,共3页 Journal of Cancer Control And Treatment
关键词 胃癌 基质金属蛋白酶 侵袭 转移 标记物 Gastric Cancer Matrix Metalloproteinase Invasion Metastasis Marker
  • 相关文献

参考文献7

二级参考文献21

  • 1钟崇,郭荣平,石明,韦玮,俞武生,李锦清.VEGF与MMP-9在肝癌组织中的表达及其临床意义[J].癌症,2006,25(5):599-603. 被引量:35
  • 2Moon WS, Rhyu KH, Kang M J, et al. Overexpression of VEGF and antgiopoietin 2: a key to high vascularity of hepatocellular carcinoma[J]. Mod Pathol,2003, 16 (6) :552-557.
  • 3Suzuki K, Hayashi N, Miyamoto Y, et al. Expression of vascular permeability factor vascular endothelial growth factor in human hepatocellular carcinoma[ J ]. Cancer Res, 1996,56 ( 13 ) :3004 - 3009.
  • 4Hee J, Soo KB, Ho Y, et al. Anti - invasive activity of ur - soliecid correlates with the reduced expression of matrix metal loproteinase-9 (MMP -9) in HT - 1080 human fibrosarcoma cells[J]. Cancer Res, 1996,56(10) :2281 -2285.
  • 5Zueker S,Lysik RM,Zarrabi MH,et al.M(r)92 000 type Ⅳcollagenase is increased in plasma of patients with colon cancer and breast cancer[J].Cancer Res,1993,53(1):140-146.
  • 6Zeng ZS, Guillem JG. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases [ J ]. Br J Cancer,1995, 72(3) :575-582.
  • 7Varani J, Hattori Y, Dame MK, et al. Matrix metalloproteinases (MMPs) in fresh human prostate tumour tissue and organ-cultured prostate tissue: levels of collagenolytic and gelatinolytic MMPs are low, variable and different in fresh tissue versus organ-cultured tissue[J]. Br J Cancer, 2001, 84(8) :1076-1083.
  • 8Trudel D, Fradet Y, Meyer F, et al. Significance of MMP-2 expression in prostate cancer: an immunohistochemical study [ J].Cancer Res, 2003, 63(23) :8511-8515.
  • 9Hamdy FC, Fadlon EJ, Cottam D, et al. Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia[ J ]. Br J Cancer, 1994, 69 ( 1 ): 177-182.
  • 10Lokeshwar BL, Selzer MG, Block NL, et al. Secretion of matrix metalloproteinases and their inhibitors ( tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues [ J ].Cancer Res, 1993, 53(19) :4493-4498.

共引文献34

同被引文献46

  • 1薛世林.血清胃蛋白酶原作为一种胃癌标记物的研究进展[J].大同医学专科学校学报,2004,24(4):24-25. 被引量:6
  • 2董绍安,赵景岚,林乐胜.食管鳞状细胞癌组织MMP-2、9与TIMP-1表达及意义[J].青岛大学医学院学报,2007,43(2):105-107. 被引量:10
  • 3李小平,岑志恒.血清MG7-Ag对胃癌诊断的应用价值[J].现代检验医学杂志,2007,22(2):37-38. 被引量:7
  • 4Crew KD, Neugut A. Epidemiology of upper gastrointestinal malignancies[J. Semin Oncol,2004,31:450 464.
  • 5Pohn H, Welch HG. The role of overdiagnosis and reclassifi cation in the marked increase of esophageal adenocarcinoma in- cidence[J. Natl Cancer Inst, 2005,97:142 146.
  • 6Parkin MD, Bray F, Ferlay J,et al. Global cancer statistics 2002[J. CA Cancer J Clin, 2005,55:74-108.
  • 7EI-Shahat M, Lofty M, Fahmy L, et al. Prognostic value of microvessel density, matrix metalloproteinase-9 and p53 pro tein expression in esophageal cancer[J. Egypt Natl Cancer Inst, 2004. 16:224 230.
  • 8Vallbohmer D, Lenz HJ. Predictive and prognostic molecular markers in outcome oi" esophageal cancer[J. Dis Esophagus, 2006,19:425-432.
  • 9Coleman MP, Gatta G, Verdecchia A, et al. Eurocare-3 sum- mary: cancer survival in Europe at the end of the 20th century [J]. AnnOncol,2003,14:128 149.
  • 10Samantaray S, Sharma R, Chattopadhyaya TK, et al. In- creased expression of MMP 2 and MMP 9 in esophageal squa- mous cell carcinoma[J. Cancer Res Clin Oncol, 2004,130: 37-44.

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部